CLAMOVID GRANULES 156.25 mg/5 ml
Product details
Registration number: SIN12027P
Classification: Prescription Only
Active ingredients:
- AMOXYCILLIN TRIHYDRATE
- CLAVULANATE POTASSIUM
Strength:
- 125 mg/5 ml
- 31.25 mg/5 ml
Dosage form: GRANULE, FOR SUSPENSION
Route: ORAL
Registrant: GOLDPLUS UNIVERSAL PTE LTD
ATC code: J01CR02
HSA approval date: 17 July 2002
Manufacturer(s): Bilim Ilac Sanayi Ve Ticaret A.S.
Manufacturing country/countries: TURKEY
What are the HSA registration number and classification for CLAMOVID GRANULES 156.25 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN12027P
Classification: Prescription Only
What active ingredients and strength are recorded for CLAMOVID GRANULES 156.25 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- AMOXYCILLIN TRIHYDRATE
- CLAVULANATE POTASSIUM
Strength:
- 125 mg/5 ml
- 31.25 mg/5 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CLAMOVID GRANULES 156.25 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: GRANULE, FOR SUSPENSION
Route: ORAL
Who is the recorded registrant for CLAMOVID GRANULES 156.25 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GOLDPLUS UNIVERSAL PTE LTD
Which manufacturers and countries are listed for CLAMOVID GRANULES 156.25 mg/5 ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Bilim Ilac Sanayi Ve Ticaret A.S.
Manufacturing country/countries: TURKEY
Where can I look up CLAMOVID GRANULES 156.25 mg/5 ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN12027P or the exact product name CLAMOVID GRANULES 156.25 mg/5 ml. The general register link does not preselect this product.
What are the source dates for this CLAMOVID GRANULES 156.25 mg/5 ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CLAMOVID GRANULES 156.25 mg/5 ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN12027P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)